Literature DB >> 10836322

Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma.

P Paredi1, M J Leckie, I Horvath, L Allegra, S A Kharitonov, P J Barnes.   

Abstract

Carbon monoxide is a product of haem degradation by haem oxygenase (HO), activated by inflammatory cytokines and oxidants. This study examined whether allergen challenge can increase exhaled CO levels, as a reflection of HO activation. Exhaled CO and nitric oxide, an expired gas also thought to reflect cytokine-induced airway inflammation, were measured in 15 atopic steroid-naive nonsmoking patients with asthma (13 males, aged 30+/-2 yrs) before and for up to 20 h after allergen challenge. Baseline CO (4.4+/-0.3 parts per million (ppm)) and NO (20.6+/-1.2 parts per billion (ppb)) levels were elevated in asthmatic as compared with nonsmoking normal volunteers (n = 37, 2.1+/-0.2 ppm and 7.0+/-0.1 ppb, respectively, p<0.05). In 10 patients with a dual response in the forced expiratory volume in one second (FEV1) there was a maximal increase in exhaled CO at 1 h (343+/-7.1%) and at 6 h (69+/-12%, p<0.01), followed by a maximal fall in FEV1 (28+/-9%, p<0.05) at 9 h, whereas the maximal NO increase was observed at 10 h (50.2+/-11.8%). The maximal increase in exhaled CO in single response patients (n = 5) was 30+/-2% during the early asthmatic reaction and 46.3+/-9.2% between 4 and 10 h, followed by a fall in FEV1 (9+/-3%, p>0.05) at 9 h, whereas exhaled NO was not significantly changed. In five patients exhaled CO was not attenuated by inhalation of increasing concentrations of histamine causing a 20% fall in FEV1 (PC20) or its subsequent relief by beta2-agonists. In conclusion, exhaled carbon monoxide is increased during the early and late asthmatic reactions independently of the change in airway calibre, while exhaled nitric oxide is increased only during the late reaction and follows the increase in carbon monoxide and fall in the forced expiratory volume in one second in time.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10836322     DOI: 10.1183/09031936.99.13104899

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  16 in total

1.  Changes in exhaled nitric oxide levels after bronchial allergen challenge.

Authors:  María Pedrosa; Pilar Barranco; Valentín López-Carrasco; Santiago Quirce
Journal:  Lung       Date:  2012-01-07       Impact factor: 2.584

2.  Fractional exhaled nitric oxide in the interpretation of specific inhalational challenge tests for occupational asthma.

Authors:  Gareth I Walters; Vicky C Moore; Emmet E McGrath; Sherwood Burge
Journal:  Lung       Date:  2014-02       Impact factor: 2.584

Review 3.  [Carbon monoxide--poison or potential therapeutic?].

Authors:  A Hoetzel; R Schmidt
Journal:  Anaesthesist       Date:  2006-10       Impact factor: 1.041

Review 4.  The role of heme oxygenase-1 in pulmonary disease.

Authors:  Laura E Fredenburgh; Mark A Perrella; S Alex Mitsialis
Journal:  Am J Respir Cell Mol Biol       Date:  2006-09-15       Impact factor: 6.914

5.  Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma.

Authors:  C Ward; M Pais; R Bish; D Reid; B Feltis; D Johns; E H Walters
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

6.  Uptake of carbon monoxide and hydrogen at environmentally relevant concentrations by mycobacteria.

Authors:  Gary M King
Journal:  Appl Environ Microbiol       Date:  2003-12       Impact factor: 4.792

Review 7.  Exhaled carbon monoxide in asthmatics: a meta-analysis.

Authors:  Jingying Zhang; Xin Yao; Rongbin Yu; Jianling Bai; Yun Sun; Mao Huang; Ian M Adcock; Peter J Barnes
Journal:  Respir Res       Date:  2010-04-30

Review 8.  Carbon monoxide in exhaled breath testing and therapeutics.

Authors:  Stefan W Ryter; Augustine M K Choi
Journal:  J Breath Res       Date:  2013-02-27       Impact factor: 3.262

9.  A meta-analysis of the association of exhaled carbon monoxide on asthma and allergic rhinitis.

Authors:  Yu Shaoqing; Zhang Ruxin; Chen Yingjian; Chen Jianqiu; Wang Yanshen; Li Genhong
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

10.  Assessment of airway inflammation with exhaled NO measurement.

Authors:  E Hatziagorou; J Tsanakas
Journal:  Hippokratia       Date:  2007-04       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.